Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Nuclear hyaluronidase 2 drives alternative splicing of CD44 pre-mRNA to determine profibrotic or antifibrotic cell phenotype.

Midgley AC, Oltean S, Hascall V, Woods EL, Steadman R, Phillips AO, Meran S.

Sci Signal. 2017 Nov 21;10(506). pii: eaao1822. doi: 10.1126/scisignal.aao1822.

PMID:
29162741
2.

Understanding Electronic AKI Alerts: Characterization by Definitional Rules.

Holmes J, Roberts G, Meran S, Williams JD, Phillips AO; Welsh AKI Steering Group.

Kidney Int Rep. 2016 Dec 9;2(3):342-349. doi: 10.1016/j.ekir.2016.12.001. eCollection 2017 May.

3.

Tumor Necrosis Factor-stimulated Gene 6 (TSG-6)-mediated Interactions with the Inter-α-inhibitor Heavy Chain 5 Facilitate Tumor Growth Factor β1 (TGFβ1)-dependent Fibroblast to Myofibroblast Differentiation.

Martin J, Midgley A, Meran S, Woods E, Bowen T, Phillips AO, Steadman R.

J Biol Chem. 2016 Jun 24;291(26):13789-801. doi: 10.1074/jbc.M115.670521. Epub 2016 May 3.

4.

Regulation of synthesis and roles of hyaluronan in peritoneal dialysis.

Bowen T, Meran S, Williams AP, Newbury LJ, Sauter M, Sitter T.

Biomed Res Int. 2015;2015:427038. doi: 10.1155/2015/427038. Epub 2015 Oct 13. Review.

5.

The impact of acute kidney injury in diabetes mellitus.

Johnson F, Phillips D, Talabani B, Wonnacott A, Meran S, Phillips AO.

Nephrology (Carlton). 2016 Jun;21(6):506-11. doi: 10.1111/nep.12649.

PMID:
26452246
6.

How good are we at managing acute kidney injury in hospital?

Meran S, Wonnacott A, Amphlett B, Phillips A.

Clin Kidney J. 2014 Apr;7(2):144-50. doi: 10.1093/ckj/sfu010. Epub 2014 Feb 28.

7.

Hyaluronan regulates bone morphogenetic protein-7-dependent prevention and reversal of myofibroblast phenotype.

Midgley AC, Duggal L, Jenkins R, Hascall V, Steadman R, Phillips AO, Meran S.

J Biol Chem. 2015 May 1;290(18):11218-34. doi: 10.1074/jbc.M114.625939. Epub 2015 Feb 25.

8.

Epidemiology and outcomes in community-acquired versus hospital-acquired AKI.

Wonnacott A, Meran S, Amphlett B, Talabani B, Phillips A.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1007-14. doi: 10.2215/CJN.07920713. Epub 2014 Mar 27.

9.

Epidemiology and outcome of community-acquired acute kidney injury.

Talabani B, Zouwail S, Pyart RD, Meran S, Riley SG, Phillips AO.

Nephrology (Carlton). 2014 May;19(5):282-7. doi: 10.1111/nep.12221.

PMID:
24571827
10.

The long-term impact of eGFR reporting on referral patterns.

Phillips LA, Phillips BM, Meran S, Russell J, Zouwail S, Riley SG, Phillips AO.

Eur J Intern Med. 2014 Jan;25(1):97-101. doi: 10.1016/j.ejim.2013.08.001. Epub 2013 Aug 28.

PMID:
23993052
11.

Interleukin-1β induces hyaluronan and CD44-dependent cell protrusions that facilitate fibroblast-monocyte binding.

Meran S, Martin J, Luo DD, Steadman R, Phillips A.

Am J Pathol. 2013 Jun;182(6):2223-40. doi: 10.1016/j.ajpath.2013.02.038. Epub 2013 Apr 11.

PMID:
23583650
12.

A simple screening test for the detection of erythropoietin antibodies.

Meran S, Wonnacott A, Davies M, Ellis R, Phillips A.

Clin Nephrol. 2014 Sep;82(3):215-20. doi: 10.5414/CN107864.

PMID:
23391321
13.

Applying estimated glomerular filtration rate to an ageing population: are we in danger of becoming ageist?

Wonnacott A, Meran S, Roberts G, Donovan K, Riley S, Phillips AO.

Eur J Intern Med. 2012 Dec;23(8):705-10. doi: 10.1016/j.ejim.2012.08.012. Epub 2012 Sep 26.

PMID:
23021873
14.

Tumour necrosis factor-stimulated gene (TSG)-6 controls epithelial-mesenchymal transition of proximal tubular epithelial cells.

Bommaya G, Meran S, Krupa A, Phillips AO, Steadman R.

Int J Biochem Cell Biol. 2011 Dec;43(12):1739-46. doi: 10.1016/j.biocel.2011.08.009. Epub 2011 Aug 16.

PMID:
21864707
15.

Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.

Meran S, Luo DD, Simpson R, Martin J, Wells A, Steadman R, Phillips AO.

J Biol Chem. 2011 May 20;286(20):17618-30. doi: 10.1074/jbc.M111.226563. Epub 2011 Mar 25.

16.

Fibroblasts and myofibroblasts in renal fibrosis.

Meran S, Steadman R.

Int J Exp Pathol. 2011 Jun;92(3):158-67. doi: 10.1111/j.1365-2613.2011.00764.x. Epub 2011 Feb 28. Review.

17.

Impact of chronic kidney disease management in primary care.

Meran S, Don K, Shah N, Donovan K, Riley S, Phillips AO.

QJM. 2011 Jan;104(1):27-34. doi: 10.1093/qjmed/hcq151. Epub 2010 Aug 30.

PMID:
20805119
18.

Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation.

Simpson RM, Meran S, Thomas D, Stephens P, Bowen T, Steadman R, Phillips A.

Am J Pathol. 2009 Nov;175(5):1915-28. doi: 10.2353/ajpath.2009.090045. Epub 2009 Oct 1.

19.

Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan.

Webber J, Jenkins RH, Meran S, Phillips A, Steadman R.

Am J Pathol. 2009 Jul;175(1):148-60. doi: 10.2353/ajpath.2009.080837. Epub 2009 Jun 18.

20.

Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype.

Webber J, Meran S, Steadman R, Phillips A.

J Biol Chem. 2009 Apr 3;284(14):9083-92. doi: 10.1074/jbc.M806989200. Epub 2009 Feb 4.

21.

Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation.

Meran S, Thomas DW, Stephens P, Enoch S, Martin J, Steadman R, Phillips AO.

J Biol Chem. 2008 Mar 7;283(10):6530-45. doi: 10.1074/jbc.M704819200. Epub 2008 Jan 2.

22.

Involvement of hyaluronan in regulation of fibroblast phenotype.

Meran S, Thomas D, Stephens P, Martin J, Bowen T, Phillips A, Steadman R.

J Biol Chem. 2007 Aug 31;282(35):25687-97. Epub 2007 Jul 3.

Supplemental Content

Support Center